The U.S. Food and Drug Administration approved Arrowhead Pharmaceuticals' drug for a type of genetic disorder that causes ...
Plozasiran is an apoC-III-directed small interfering ribonucleic acid designed to reduce levels of hepatic and serum apoC-III ...
An analysis of federal data shows a pronounced decline, despite alarming conditions found at some manufacturers.
The next generation of weight loss drugs will hit the market in 2026. Eli Lilly and Novo Nordisk are racing to the finish line.
A menopause researcher breaks down the biggest myths women get wrong about hot flashes, plus the hormonal and non-hormonal ...
Researchers reported that Eli Lilly’s GLP-1 weight-loss drug appeared to temporarily suppress food-craving signals in the ...
One of the most highly regulated sectors in the U.S. food industry is still too vulnerable to contamination.
For more than 20 years, hormone therapy for menopause has carried a warning label from the Food and Drug Administration ...
In recent weeks, at least 23 infants in the U.S. have been infected with botulism in an outbreak linked to ByHeart powdered ...
The Food and Drug Administration shouldn’t be in the news if it’s doing its job right. By that measure the FDA is failing in spectacular fashion. The agency this week is making news for all of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback